GLP-1 medications, such as semaglutide and tirzepatide, are gaining attention for their ability to support weight loss and improve metabolic health.
Vigor Compounding partners with healthcare providers by offering high-quality compounded semaglutide and tirzepatide, both formulated with vitamin B6.
As a 503A compounding pharmacy, we understand the importance of quality prescriptions. We also know that before treatment begins, obtaining informed consent is a must for legal protection and patient trust.
This blog walks you through the essential components to cover in your documentation for GLP-1 therapies.
Why Informed Consent Matters
Clear, well-structured informed consent documents protect your practice and help patients make confident, educated decisions. A thorough form also reinforces transparency, which is vital when working with compounded drugs. Typically, providers need to obtain their patients’ signatures on these documents and cover many of the same subjects during a verbal discussion about the proposed treatment plan.
Elements to Include in Your GLP-1 Informed Consent Form
Here are some of the sections that GLP-1 informed consent forms usually contain.
Therapy Overview
Documents should include a brief explanation of GLP-1 receptor agonists and their role in weight management. It’s a good idea to clarify the difference between compounded medications and FDA-approved name brands.
Treatment Expectations
Explain typical outcomes, timelines, and realistic projections for weight loss. You should emphasize the importance of a balanced diet, regular exercise, and follow-up care as well.
Potential Risks and Side Effects
Discuss the following:
- Common side effects
- Serious risks
- Interactions with other drugs
Off-Label and Compounded Use Disclosure
Your forms should feature a statement that the therapy involves compounded prescriptions. Acknowledge the off-label use if you’re not addressing type 2 diabetes.
Patient Responsibilities
Your patients are responsible for:
- Adherence to dosing schedules
- Reporting adverse events or symptoms
- Agreeing to ongoing monitoring and follow-up appointments
Alternatives to Treatment
Mention other medical or non-medical weight loss options. Let patients know they have the right to decline or discontinue treatment at any time as well.
Set Your Practice Up for Success
Informed consent is more than paperwork. It’s a foundational step in patient care. You can consider the elements above when drafting forms for your clinic.
A clear and complete form sets appropriate expectations, reduces liability, and builds trust. The quality of your medication also matters when providing GLP-1 therapy.
If you’re looking for a pharmacy partner to support your GLP-1 offerings, Vigor Compounding is here to help. Reach out today to learn how we can assist with your prescribing needs.
